X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1588) 1588
Publication (128) 128
Book Review (40) 40
Newsletter (40) 40
Book Chapter (8) 8
Magazine Article (5) 5
Conference Proceeding (4) 4
Newspaper Article (3) 3
Transcript (2) 2
Book / eBook (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1208) 1208
baclofen (876) 876
male (765) 765
index medicus (667) 667
female (586) 586
adult (513) 513
baclofen - administration & dosage (484) 484
baclofen - adverse effects (475) 475
clinical neurology (444) 444
baclofen - therapeutic use (443) 443
middle aged (409) 409
spasticity (365) 365
muscle spasticity - drug therapy (308) 308
muscle relaxants, central - administration & dosage (262) 262
injections, spinal (254) 254
treatment outcome (254) 254
intrathecal baclofen (237) 237
neurosciences (232) 232
pharmacology & pharmacy (217) 217
adolescent (211) 211
muscle relaxants, central - adverse effects (206) 206
aged (192) 192
child (184) 184
management (175) 175
care and treatment (174) 174
animals (173) 173
muscle relaxants, central - therapeutic use (171) 171
muscle spasticity - etiology (161) 161
double-blind (156) 156
gaba (148) 148
rehabilitation (145) 145
pediatrics (133) 133
psychiatry (133) 133
drug therapy (131) 131
dose-response relationship, drug (126) 126
infusion pumps, implantable - adverse effects (126) 126
surgery (125) 125
therapy (125) 125
infusion (122) 122
cerebral palsy (120) 120
baclofen - pharmacology (117) 117
central nervous system depressants (115) 115
infusion pumps, implantable (114) 114
rats (113) 113
children (111) 111
neurology (110) 110
double-blind method (109) 109
young adult (104) 104
medicine & public health (100) 100
pain (99) 99
retrospective studies (98) 98
drugs (97) 97
analysis (92) 92
alcoholism (91) 91
efficacy (91) 91
medicine, general & internal (87) 87
research (87) 87
child, preschool (86) 86
complications (85) 85
alcoholism - drug therapy (84) 84
follow-up studies (80) 80
dosage and administration (79) 79
time factors (79) 79
cerebral palsy - drug therapy (78) 78
gaba agonists - therapeutic use (78) 78
placebo-controlled trial (77) 77
health aspects (76) 76
multiple sclerosis (76) 76
safety (72) 72
cerebral-palsy (71) 71
gastroenterology & hepatology (71) 71
patients (71) 71
substance abuse (69) 69
withdrawal (68) 68
anesthesiology (67) 67
medical research (66) 66
internal medicine (65) 65
spinal cord injuries - complications (65) 65
dystonia (61) 61
gabapentin (61) 61
severity of illness index (61) 61
clinical trials (60) 60
gaba agonists - adverse effects (60) 60
pharmacotherapy (59) 59
injections, spinal - adverse effects (58) 58
symptoms (58) 58
administration, oral (57) 57
cerebral palsy - complications (56) 56
drug administration schedule (56) 56
muscle spasticity (56) 56
complications and side effects (55) 55
nervous system (55) 55
origin (55) 55
overdose (55) 55
gaba-b receptor agonists - therapeutic use (53) 53
medicine, research & experimental (53) 53
brain (52) 52
equipment failure (52) 52
gaba-b receptor agonists - adverse effects (52) 52
gastroesophageal reflux (52) 52
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1562) 1562
French (28) 28
German (14) 14
Spanish (13) 13
Japanese (12) 12
Russian (7) 7
Dutch (5) 5
Czech (3) 3
Italian (3) 3
Polish (2) 2
Finnish (1) 1
Hungarian (1) 1
Norwegian (1) 1
Persian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Supportive Care in Cancer, ISSN 0941-4355, 6/2011, Volume 19, Issue 6, pp. 833 - 841
Chemotherapy-induced peripheral neuropathy (CIPN) is a troublesome chronic symptom that has no proven pharmacologic treatment. The purpose of this double-blind... 
Pain Medicine | Rehabilitation Medicine | Nursing | Medicine & Public Health | Topical gel | Oncology | CIPN | BAK-PLO | Nursing Management/Nursing Research | MANAGEMENT | AMITRIPTYLINE | EFFICACY | MODEL | COMBINATION | NEUROTOXICITY | PACLITAXEL | KETAMINE | PAIN SYNDROMES | ONCOLOGY | TAXOL | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | Excitatory Amino Acid Antagonists - therapeutic use | Peripheral Nervous System Diseases - chemically induced | GABA-B Receptor Agonists - therapeutic use | Humans | Middle Aged | Male | GABA-B Receptor Agonists - adverse effects | Administration, Cutaneous | GABA-B Receptor Agonists - administration & dosage | Ketamine - administration & dosage | Baclofen - adverse effects | Ketamine - adverse effects | Lecithins - chemistry | Antineoplastic Agents - adverse effects | Female | Ketamine - therapeutic use | Excitatory Amino Acid Antagonists - adverse effects | Baclofen - therapeutic use | Poloxamer - chemistry | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Gels | Baclofen - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Treatment Outcome | Amitriptyline - adverse effects | Adrenergic Uptake Inhibitors - administration & dosage | Aged | Amitriptyline - therapeutic use | Drug Combinations | Peripheral Nervous System Diseases - drug therapy | Amitriptyline - administration & dosage | Amitriptyline | Chemotherapy | Lecithin | Baclofen | Clinical trials | Research | Cancer | Side effects | Drug therapy | Neurological disorders | Index Medicus
Journal Article
Archives of Physical Medicine and Rehabilitation, ISSN 0003-9993, 2014, Volume 95, Issue 6, pp. 1032 - 1038
Abstract Objective To assess the frequency and types of adverse events (AEs) related to intrathecal baclofen (ITB) therapy in adults, and associated risk... 
Physical Medicine and Rehabilitation | Rehabilitation | Infusion pumps, implantable | Adverse drug event | Muscle spasticity | Baclofen | SPORT SCIENCES | MANAGEMENT | TOLERANCE | PUMP | CHILDREN | THERAPY | COMPLICATIONS | SEVERE SPINAL SPASTICITY | CEREBRAL-PALSY | Multiple Sclerosis - diagnosis | Age Distribution | Prospective Studies | Spinal Cord Injuries - drug therapy | Follow-Up Studies | Spinal Cord Injuries - complications | Humans | Middle Aged | Male | Long-Term Care | Muscle Spasticity - drug therapy | Incidence | Baclofen - adverse effects | Dose-Response Relationship, Drug | Young Adult | Time Factors | Cerebral Palsy - diagnosis | Statistics, Nonparametric | Adult | Female | Baclofen - therapeutic use | Severity of Illness Index | Infusion Pumps, Implantable | Drug Administration Schedule | Drug-Related Side Effects and Adverse Reactions - etiology | Treatment Outcome | Drug-Related Side Effects and Adverse Reactions - epidemiology | Multiple Sclerosis - complications | Muscle Spasticity - etiology | Cerebral Palsy - complications | Cerebral Palsy - drug therapy | Adolescent | Sex Distribution | Muscle Relaxants, Central - adverse effects | Aged | Muscle Spasticity - physiopathology | Injections, Spinal - adverse effects | Muscle Relaxants, Central - therapeutic use | Spinal Cord Injuries - diagnosis | Multiple Sclerosis - drug therapy | Complications and side effects | Adults | Central nervous system depressants | Hospitals, Military
Journal Article
Clinical Neurology and Neurosurgery, ISSN 0303-8467, 2011, Volume 114, Issue 6, pp. 577 - 584
Abstract Objective To investigate the existence of an association between formation of catheter tip intrathecal inflammatory masses with opioid dose and/or... 
Neurology | Neurosurgery | Intrathecal drug delivery systems | Systematic review | Catheter tip granuloma | Opioid concentration | Opioid dose | SURGERY | MANAGEMENT | BACLOFEN | CHRONIC PAIN | CATHETER GRANULOMAS | TIP INFLAMMATORY MASSES | BUPIVACAINE | CLINICAL NEUROLOGY | MORPHINE THERAPY | PATIENT | SPINAL-CORD COMPRESSION | DRUG INFUSION | Infusion Pumps, Implantable - adverse effects | Humans | Middle Aged | Male | Risk | Analgesics, Opioid - adverse effects | Adrenergic alpha-Agonists - administration & dosage | Adrenergic alpha-Agonists - adverse effects | Catheters - adverse effects | Catheters, Indwelling - adverse effects | Adult | Female | Granuloma - chemically induced | Data Interpretation, Statistical | Bupivacaine - administration & dosage | Clonidine - adverse effects | Granuloma - pathology | Spinal Cord Diseases - chemically induced | Analgesics, Opioid - administration & dosage | Aged | Spinal Cord Diseases - pathology | Clonidine - administration & dosage | Bupivacaine - adverse effects | Injections, Spinal - adverse effects | Morphine - administration & dosage | Morphine - adverse effects | Drugs | Granuloma | Drug delivery systems | Analysis | Vehicles | Studies | Spinal cord | Pain | Drug therapy | Drug dosages | Catheters | Literature reviews | Databases | Opioids | Case reports | Data processing | Morphine | Inflammation | Age
Journal Article
Journal Article
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2015, Volume 3, Issue 6, p. CD010750
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2015, Volume 25, Issue 10, pp. 1631 - 1636
Journal Article
Critical Care Medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S244 - S252
Hyperthermia is frequently seen in the intensive care setting and is associated with significant morbidity and mortality. It is often initially misdiagnosed as... 
Cyproheptadine | Temperature | Serotonin | Neuroleptic | Baclofen | Dantrolene | Malignant | Hyperthermia | Fever | SEROTONIN SYNDROME | hyperthermia | MANAGEMENT | fever | malignant | baclofen | INTRATHECAL BACLOFEN WITHDRAWAL | THERMOREGULATION | serotonin | CARDIAC-ARREST | cyproheptadine | temperature | NEUROLEPTIC MALIGNANT SYNDROME | dantrolene | CONTRACTURE TEST | neuroleptic | OF-THE-LITERATURE | CRITICAL CARE MEDICINE | Critical Care - methods | Malignant Hyperthermia - physiopathology | Drug-Related Side Effects and Adverse Reactions - complications | United States | Humans | Fever - therapy | Substance Withdrawal Syndrome - therapy | Fever - chemically induced | Malignant Hyperthermia - therapy | Fever - physiopathology | Baclofen - adverse effects | Neuroleptic Malignant Syndrome - therapy | Serotonin Syndrome - physiopathology | Neuroleptic Malignant Syndrome - physiopathology | Intensive Care Units | Fever - diagnosis | Serotonin Syndrome - therapy | Malignant Hyperthermia - diagnosis | Serotonin Syndrome - diagnosis | Substance Withdrawal Syndrome - physiopathology | Drug-Related Side Effects and Adverse Reactions - physiopathology | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - therapy | Substance Withdrawal Syndrome - diagnosis | Neuroleptic Malignant Syndrome - diagnosis
Journal Article
Journal Article